Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Receivables: 2020-2024

Historic Receivables for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $2.7 million.

  • Molecular Partners Ag's Receivables fell 31.35% to $2,629 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 19.97%. This contributed to the annual value of $2.7 million for FY2024, which is 3496.61% up from last year.
  • As of FY2024, Molecular Partners Ag's Receivables stood at $2.7 million, which was up 3,496.61% from $75,662 recorded in FY2023.
  • Molecular Partners Ag's 5-year Receivables high stood at $4.4 million for FY2020, and its period low was $75,662 during FY2023.
  • For the 3-year period, Molecular Partners Ag's Receivables averaged around $958,612, with its median value being $78,909 (2022).
  • In the last 5 years, Molecular Partners Ag's Receivables crashed by 95.73% in 2021 and then soared by 3,496.61% in 2024.
  • Yearly analysis of 5 years shows Molecular Partners Ag's Receivables stood at $4.4 million in 2020, then tumbled by 95.73% to $186,155 in 2021, then crashed by 57.61% to $78,909 in 2022, then fell by 4.12% to $75,662 in 2023, then skyrocketed by 3,496.61% to $2.7 million in 2024.